GSK PLC (GSK)
Clinical trial NCT06412120 updates: 1. start date: 2026-08-01 → 2026-06-08 2. completion date: 2031-08-01 → 2031-06-08 3. primary completion date: 2029-08-01 → 2029-06-08
Clinical trial NCT06412120 updates: 1. start date: 2026-08-01 → 2026-06-08 2. completion date: 2031-08-01 → 2031-06-08 3. primary completion date: 2029-08-01 → 2029-06-08
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical